EGFR and lung carcinoma: Currently, a number of miRNAs has been described which may have a specific role in lung cancer pathogenesis, biological and clinical disease behaviour as well as in modulating response to anticancer treatments, particularly EGFR-TKIs (Table 2) [60–63].